Here are four things to know:
- The study monitored 200 patients with ischemic heart disease to evaluate adherence to a wearable device. For the study, patients were asked to use a Fitbit Charge 2.
- The researchers found high adherence (90 percent on average) and low attrition rates (.09 percent decrease per day) over a 90-day period.
- Devices with heart rate monitors can “record useful patient statistics including activity level, resting and active HR, and sleep time,” the study reads.
- The study suggests consumer-grade wearables could be used to help telemonitor select patients, as data generated from a device like a Fitbit “correlate with clinically used patient surveys, and therefore might be an effective way of identifying patients who require intervention.”
Click here to read the full study.
More articles on telehealth:
EpicMD launches new mobile platform
Global telemedicine market to hit $48.8B by 2023
5 critical factors for a successful telehealth program
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.